Carter, GP, Rood, JI, Lyras, D. The role of toxin A and toxin B in the virulence of Clostridium difficile
. Trends in Microbiology
2012; 20(1): 21–29.
Eckert, C, et al.
Prevalence and pathogenicity of binary toxin-positive Clostridium difficile strains that do not produce toxins A and B. New Microbes and New Infections
2015; 3: 12–17.
Martin, JSH, Monaghan, TM, Wilcox, MH.
Clostridium difficile infection: epidemiology, diagnosis and understanding transmission. Nature Reviews Gastroenterology & Hepatology
2016; 13(4): 206–216.
Clostridium difficile infection in the twenty-first century. Emerging Microbes & Infections
2013; 2: e62.
Sartelli, M, et al.
WSES guidelines for management of Clostridium difficile infection in surgical patients. World Journal of Emergency Surgery
2015; 10: 38.
Heinlen, L, Ballard, JD.
Clostridium difficile infection. The American Journal of the Medical Sciences
2010; 340(3): 247–252.
Barbut, F, Jones, G, Eckert, C. Epidemiology and control of Clostridium difficile infections in healthcare settings: an update. Current Opinion in Infectious Diseases
2011; 24(4): 370–376.
Furuya-Kanamori, L, et al.
Asymptomatic Clostridium difficile colonization: epidemiology and clinical implications. BMC Infectious Diseases
2015; 15: 516.
Lo Vecchio, A, Zacur, GM.
Clostridium difficile infection: an update on epidemiology, risk factors, and therapeutic options. Current Opinion in Gastroenterology
2012; 28(1): 1–9.
Gilca, R, et al.
Epidemiological patterns and hospital characteristics associated with increased incidence of Clostridium difficile infection in Quebec, Canada, 1998–2006. Infection Control & Hospital Epidemiology
2010; 31(9): 939–947.
Vedantam, G, et al.
Clostridium difficile infection: toxins and non-toxin virulence factors, and their contributions to disease establishment and host response. Gut Microbes
2012; 3(2): 121–134.
Carter, GP, et al.
The anti-sigma factor TcdC modulates hypervirulence in an epidemic BI/NAP1/027 clinical isolate of Clostridium difficile
. PLoS Pathogens
2011; 7(10): e1002317.
Crobach, MJT, et al.
European society of clinical microbiology and infectious diseases: update of the diagnostic guidance document for Clostridium difficile infection. Clinical Microbiology & Infection
2016; 22: S63–S81.
Collins, DA, Hawkey, PM, Riley, TV. Epidemiology of Clostridium difficile infection in Asia. Antimicrobial Resistance & Infection Control
2013; 2(1): 21.
Mavros, MN, et al.
Underestimation of Clostridium difficile infection among clinicians: an international survey. European Journal of Clinical Microbiology & Infectious Diseases
2012; 31(9): 2439–2444.
Boey, CC, Ramanujam, TM, Looi, LM.
Clostridium difficile-related necrotizing pseudomembranous enteritis in association with Henoch-Schonlein purpura. Journal of Pediatric Gastroenterology & Nutrition
1997; 24(4): 426–429.
Hassan, H, Cheng, SC. Detection of Clostridium difficile from an enhancement broth by gas-liquid chromatography. The Malaysian Journal of Pathology
1991; 13(1): 29–31.
Parasakthi, N, et al.
Clostridium difficile associated diarrhoea: a report of seven cases. Singapore Medical Journal
1988; 29(5): 504–507.
Hassan, SA, et al.
Prevalence of Clostridium difficile toxin in diarhoeal stool samples of patients from a tertiary hospital in North Eastern Peninsular Malaysia. The Medical Journal of Malaysia
2012; 67(4): 402–405.
Syuhada, N, et al.
Clostridium difficile infection: clinico-epidemiological perspective. Medicine & Health
2013; 8(2): 64–72.
McDonald, LC, et al.
Recommendations for surveillance of Clostridium difficile-associated disease. Infection Control and Hospital Epidemiology
2007; 28(2): 140–145.
Putsathit, P, et al.
Evaluation of the BD Max Cdiff assay for the detection of toxigenic Clostridium difficile in human stool specimens. Pathology
2015; 47(2): 165–168.
Kato, N, et al.
Identification of toxigenic Clostridium difficile by the polymerase chain reaction. Journal of Clinical Microbiology
1991; 29(1): 33–37.
Kato, H, et al.
Identification of toxin A-negative, toxin B-positive Clostridium difficile by PCR. Journal of Clinical Microbiology
1998; 36(8): 2178–2182.
Stubbs, S, et al.
Production of actin-specific ADP-ribosyltransferase (binary toxin) by strains of Clostridium difficile
. FEMS Microbiology Letters
2000; 186(2): 307–312.
Stubbs, SL, et al.
PCR targeted to the 16S-23S rRNA gene intergenic spacer region of Clostridium difficile and construction of a library consisting of 116 different PCR ribotypes. Journal of Clinical Microbiology
1999; 37(2): 461–463.
Putsathit, P, et al.
Clostridium difficile infection in Thailand. International Journal of Antimicrobial Agents
2015; 45(1): 1–7.
Hassan, SA, et al.
Hospital-acquired Clostridium difficile infection among patients with type 2 diabetes mellitus in acute medical wards. The Journal of the Royal College of Physicians of Edinburgh
2013; 43(2): 103–107.
Putsathit, P, et al.
Prevalence and molecular epidemiology of Clostridium difficile infection in Thailand. New Microbes and New Infections
2017; 15: 27–32.
Al-Tureihi, FIJ, et al.
Albumin, length of stay, and proton pump inhibitors: key factors in Clostridium difficile-associated disease in nursing home patients. Journal of the American Medical Directors Association
2005; 6(2): 105–108.
Dubberke, ER, et al.
Risk factors for acquisition and loss of Clostridium difficile colonization in hospitalized patients. Antimicrobial Agents & Chemotherapy
2015; 59(8): 4533–4543.
Alasmari, F, et al.
Prevalence and risk factors for asymptomatic Clostridium difficile carriage. Clinical Infectious Diseases
2014; 59(2): 216–222.
McPherson, S, et al.
Intravenous immunoglobulin for the treatment of severe, refractory, and recurrent Clostridium difficile diarrhea. Diseases of the Colon & Rectum
2006; 49(5): 640–645.
Hardt, C, et al.
Univariate and multivariate analysis of risk factors for severe Clostridium difficile-associated diarrhoea: importance of co-morbidity and serum C-reactive protein. World Journal of Gastroenterology
2008; 14(27): 4338–4341.
Francino, MP. Antibiotics and the human gut microbiome: dysbioses and accumulation of resistances. Frontiers in Microbiology
2015; 6: 1543.
Langdon, A, Crook, N, Dantas, G. The effects of antibiotics on the microbiome throughout development and alternative approaches for therapeutic modulation. Genome Medicine
2016; 8: 39.
Ziakas, PD, et al.
Asymptomatic carriers of toxigenic C. difficile in long-term care facilities: a meta-analysis of prevalence and risk factors. PLoS ONE
2015; 10(2): e0117195.